What are the side effects of Etizolam?

Users most often report addiction, rebound anxiety, insomnia, seizure risk, dependence. Side effects came up 11 times across 31 reports.

User reports can't establish safety. PubMed lists 2 meta-analyses and 10 randomized trials. Talk to a doctor or pharmacist, especially if you take other medication.

Etizolam side effects

Across 31 first-hand reports, people mentioned a side effect 11 times (about 35 per 100 reports). The most common: addiction, rebound anxiety, insomnia. User reports show what people notice — they can't tell you whether Etizolam is safe for you.

Reported side effects

addiction5

rebound anxiety1

insomnia1

seizure risk1

dependence1

withdrawal1

drowsiness1

In their own words

“I used etizolam daily for about 3-4 years. Coming off of them was the worse thing I have ever experienced. I was severely sick and in a state of constant panic for the first 2 months.”

Didn't helpRead the discussion ↗

“etizolam puts me right to sleep. I mean I have to fight to stay awake.”

HelpedRead the discussion ↗

“the life I was living —— sleeping over ten hours a day and consuming enormous amounts of Etizolam to escape my nihilistic point of view”

Didn't helpRead the discussion ↗

“Etizolam... Doesn't seem to have the same lingering effects as the benzos and definitely impacts my memory less severely than benzos... I'm sure it's addictive as fuck”

MixedRead the discussion ↗

Is Etizolam safe? What the research covers

BResearch: Moderate2 meta-analyses · 10 randomized trials on PubMed

PLoS One · 2024

Systematic review: The relationship between gabapentinoids, etizolam, and drug related deaths in Scotland

Conclusion: Polydrug use was identified as the most common determinant of both etizolam and gabapentinoids related adverse effects and fatality in Scotland, especially concurrent opioid use. The results indicate the literature on individual characteristics of Scottish at-risk users of gabapentinoids and etizolam is limited, however the data shows both substances are being used by older cohort, with adverse effects seen more in older women.